Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene

por O'Connell, RJ, Polonis, VR, Ratto-Kim, S, Cox, J, Jagodzinski, LL, Malia, J, Michael, NL, Excler, J, Robb, ML, Kim, JH
Publicado 2012